Australian Institute of Health and Welfare (2021) Acute rheumatic fever and rheumatic heart disease in Australia, 2015–2019, AIHW, Australian Government, accessed 03 December 2022.
Australian Institute of Health and Welfare. (2021). Acute rheumatic fever and rheumatic heart disease in Australia, 2015–2019. Retrieved from https://pp.aihw.gov.au/reports/heart-stroke-vascular-diseases/acute-rheumatic-fever-and-rheumatic-heart-disease
Acute rheumatic fever and rheumatic heart disease in Australia, 2015–2019. Australian Institute of Health and Welfare, 16 July 2021, https://pp.aihw.gov.au/reports/heart-stroke-vascular-diseases/acute-rheumatic-fever-and-rheumatic-heart-disease
Australian Institute of Health and Welfare. Acute rheumatic fever and rheumatic heart disease in Australia, 2015–2019 [Internet]. Canberra: Australian Institute of Health and Welfare, 2021 [cited 2022 Dec. 3]. Available from: https://pp.aihw.gov.au/reports/heart-stroke-vascular-diseases/acute-rheumatic-fever-and-rheumatic-heart-disease
Australian Institute of Health and Welfare (AIHW) 2021, Acute rheumatic fever and rheumatic heart disease in Australia, 2015–2019, viewed 3 December 2022, https://pp.aihw.gov.au/reports/heart-stroke-vascular-diseases/acute-rheumatic-fever-and-rheumatic-heart-disease
Get citations as an Endnote file:
1.1 Yearly age-specific incidence rates of all episodes, and of first episodes of ARF according to
1.2 Proportion of all recorded ARF episodes classified as recurrences
1.3 Rates of ARF recurrences per 100 patient-years
1.4 Number of deaths and age-standardised rates of mortality due to ARF and RHD in the previous calendar year by ethnicity
1.5 Yearly age-specific and overall incidence of RHD by ethnicity and broken down by method found and presented
1.6 Yearly age-specific prevalence of RHD, by ethnicity
1.7 Proportion of newly registered cases of ARF or RHD with an initial recorded diagnosis being established RHD (rather than ARF)
2.1 Proportion of all people indicated for secondary prophylaxis* who are registered to receive benzathine penicillin G (BPG).
2.2 Median percentage of all scheduled BPG doses actually delivered
2.3 Proportion of people indicated for BPG secondary prophylaxis who received <50%, 50-79%, and ≥80% of scheduled doses in the previous calendar year
3.1 Proportion of all registered ARF and RHD cases classified as mild, moderate, severe and inactive
3.2 Proportion of people classified as moderate or severe RHD who had an echocardiogram within the previous 6 months, 1 year, and 1-2 years
3.3 Number of cases, and proportion of total cases indicated for cardiac surgery, who have been waiting <6 months, 6-11 months, 12-23 months, or 24+ months
3.4 Number and type of surgical procedures performed during the previous calendar year by
3.4.1 Age group
3.5 Number (and proportion) of people who died in the previous calendar year within 28 days and 1 year of undergoing rheumatic cardiac surgery by
3.5.1 Age group
* If denominator of those indicated for prophylaxis not known, use people with a history of ARF within the last 10 years, or, ARF and RHD and aged < 21 years, or, aged ≥21 years with moderate or severe RHD.
Source: RHD Australia (ARF/RHD writing group) 2012.
We'd love to know any feedback that you have about the AIHW website, its contents or reports.
The browser you are using to browse this website is outdated and some features may not display properly or be accessible to you. Please use a more recent browser for the best user experience.